| Original language | English |
|---|---|
| Pages (from-to) | 9-12 |
| Number of pages | 4 |
| Journal | Personalized Medicine |
| Volume | 12 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2015 |
Keywords
- cancer
- clinical tumor sequencing
- cost-effectiveness analysis
- economic evaluation
- reimbursement
- value assessment
- whole-genome sequencing
Cite this
}
Clinical players and healthcare payers : Aligning perspectives on the cost-effectiveness of next-generation sequencing in oncology. / Doble, Brett; Lorgelly, Paula.
In: Personalized Medicine, Vol. 12, No. 1, 01.01.2015, p. 9-12.Research output: Contribution to journal › Editorial › Other › peer-review
TY - JOUR
T1 - Clinical players and healthcare payers
T2 - Aligning perspectives on the cost-effectiveness of next-generation sequencing in oncology
AU - Doble, Brett
AU - Lorgelly, Paula
PY - 2015/1/1
Y1 - 2015/1/1
KW - cancer
KW - clinical tumor sequencing
KW - cost-effectiveness analysis
KW - economic evaluation
KW - reimbursement
KW - value assessment
KW - whole-genome sequencing
UR - http://www.scopus.com/inward/record.url?scp=84920816380&partnerID=8YFLogxK
U2 - 10.2217/pme.14.81
DO - 10.2217/pme.14.81
M3 - Editorial
VL - 12
SP - 9
EP - 12
JO - Personalized Medicine
JF - Personalized Medicine
SN - 1741-0541
IS - 1
ER -